Up to 30 million Americans living with rare disease struggle to get an accurate diagnosis

February 28th 2022

Local 12

“FDNA’s Face2Gene app, combines artificial intelligence and unique technology to detect rare diseases. FDNA’s database contains thousands of patients’ pictures, and the technology can identify up to 5,000 rare diseases. “It allows clinicians to think and consider diagnoses that we would not naturally consider, for example, because a condition is so rare that even a clinical geneticist like me has never seen a patient with it,” says Dr. Gripp”

The article describes that up to 30 million Americans living with rare diseases struggle to get accurate diagnoses. FDNA aims to address this challenge with its innovative technology, Face2Gene. This AI-driven tool uses advanced facial recognition to analyze facial features and identify genetic anomalies. By comparing patient photos to a vast database of known conditions, Face2Gene provides quick and precise diagnostic suggestions. FDNA’s technology significantly improves the diagnostic process for those living with rare diseases, leading to earlier and more accurate diagnoses. This innovation highlights the transformative potential of AI in healthcare, particularly for rare disease detection.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading